Advertisement
Brief report| Volume 22, ISSUE 3, P386-389, March 1987

Depressive symptoms and the dexamethasone suppression test in parkinsonian patients

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adams EF
        • Ashby MJ
        • Brown SM
        • Wnite MC
        • Mashiter K
        Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism.
        Clin Endocrinol. 1981; 15: 479-484
        • Asnis G
        Parkinson's disease, depression and ECT: A review and case study.
        Am J Psychiatry. 1977; 134: 191-195
        • Brown GL
        • Wilson WP
        Parkinsonism and depression.
        South Med J. 1972; 65: 540-545
        • Carroll BJ
        Informed use of the Dexamethasone Suppression Test.
        J Clin Psychiatry. 1986; 47 (Suppl): 10-12
        • Carroll BJ
        • Feinberg M
        • Greden JR
        • Tarika J
        • Albala AA
        • Haskett RF
        • James NM
        • Kronfol Z
        • Lohr N
        • Steiner M
        • de Vigne JP
        • Young E
        A specifie laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.
        Arch Gen Psychiatry. 1981; 38: 15-22
        • Green HS
        • Kane JM
        The Dexamethasone Suppression Test in depression.
        Clin Neuropharmacol. 1983; 6: 7-24
        • Guillard A
        • Fenelon G
        Maladie de Parkinson et syndromes parkinsoniens.
        Encycl Med Chir Paris Neurol 17062 A10. 1983;
        • Hamilton M
        A rating scale for depression.
        J Neurol Neurosurg Psychiatry. 1960; 23: 56-62
        • Hillhouse EW
        • Burden J
        • Jones MT
        The effect of various putative neurotransmitters on the release of corticotrophin releasing hormone from the hypothalamus of the rat in vitro. I. The effect of acetylcholine and noradrenaline.
        Neuroendocrinology. 1975; 17: 1-11
        • Hoehn MM
        • Yahr MD
        Parkinsonism: Onset, progression, and mortality.
        Neurology. 1967; 17: 427-442
        • Lamberts SWJ
        • Klijn JGM
        • de Quijada M
        • Timmermans HAT
        • Uitterlinden P
        • de Jong FH
        • Birkenhager JC
        The mechanism of the suppressive action of bromocriptine on adrenocorticotrophin secretion in patients with Cushing's disease and Nelson's syndrome.
        J Clin Endocrinol Metab. 1980; 51: 307-311
        • Mayeux R
        • Stern Y
        • Rosen J
        • Leventhal J
        Depression, intellectual impairment, and Parkinson's disease.
        Neurology. 1981; 31: 645-650
        • Mayeux R
        • Stern Y
        • Cote L
        • Williams JBW
        Altered serotonin metabolism in depressed patients with Parkinson's disease.
        Neurology. 1984; 34: 642-646
        • van Loon GR
        • Hilger L
        • King AB
        • Boryczka AT
        • Ganon WF
        Inhibitory effect of 1-dihydroxyphenylalanine on the adrenal venous 17-hydroxycorticosteroid response to surgical stress in dogs.
        Endocrinology. 1971; 88: 1404-1414
        • Warburton JW
        Depressive symptoms in Parkinson patients referred for thalamotomy.
        J Neurol Neurosurg Psychiatry. 1967; 30: 368-370